AVEO Pharmaceuticals

/AVEO Pharmaceuticals

Follow-on

AVEO Pharmaceuticals

Biopharmaceutical

We are an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. Our strategy is to focus our resources toward the development and commercialization of our product candidates in North America, while leveraging partnerships to support development and commercialization in other geographies.

Symbol

AVEO

Last Closing Price
$10.35

Shares
5,000,000

Anticipated Date
March 24, 2021

Underwriters
LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for AVEO Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange